Indeed, elevated levels of TNFRII, a surrogate soluble receptor, which parallel levels of TNF-α, has been found elevated in the preclinical phase of disease of patients that go on to develop RA up to eight years after [21]. The gene discussed is TNF; the disease is rheumatoid arthritis.